Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Margolis

Showing results (461-470 of 491) with videos related to

Pageof 50
Sort By:
Ebiomedicine|July 31, 2019
Effects of testosterone supplementation on body composition and lower-body muscle function during severe exercise- and diet-induced energy deficit: A proof-of-concept, single centre, randomised, double-blind, controlled trialStefan M Pasiakos, Claire E Berryman, J Philip Karl, et al.
Nature|July 28, 2012
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyN M Archin, A L Liberty, A D Kashuba, et al.
The Journal of Infectious Diseases|March 13, 2014
HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatNancy M Archin, Rosalie Bateson, Manoj K Tripathy, et al.
The Journal of Infectious Diseases|June 5, 2020
Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral TherapyShane D Falcinelli, Bonnie E Shook-Sa, Morgan G Dewey, et al.
Mbio|September 22, 2022
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) StudyLuther A Bartelt, Alena J Markmann, Bridget Nelson, et al.
Plos Pathogens|January 4, 2014
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsCelsa A Spina, Jenny Anderson, Nancie M Archin, et al.
The Journal of Infectious Diseases|February 13, 2024
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral TherapyCynthia L Gay, Patrick J Hanley, Shane D Falcinelli, et al.
Msphere|August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent IndividualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Msphere|September 8, 2021
Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals"Alena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Pageof 50

Showing results (461-470 of 491) with videos related to

Sort By:
Pageof 50
Ebiomedicine|July 31, 2019
Effects of testosterone supplementation on body composition and lower-body muscle function during severe exercise- and diet-induced energy deficit: A proof-of-concept, single centre, randomised, double-blind, controlled trialStefan M Pasiakos, Claire E Berryman, J Philip Karl, et al.
Nature|July 28, 2012
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyN M Archin, A L Liberty, A D Kashuba, et al.
The Journal of Infectious Diseases|March 13, 2014
HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatNancy M Archin, Rosalie Bateson, Manoj K Tripathy, et al.
The Journal of Infectious Diseases|June 5, 2020
Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral TherapyShane D Falcinelli, Bonnie E Shook-Sa, Morgan G Dewey, et al.
Mbio|September 22, 2022
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) StudyLuther A Bartelt, Alena J Markmann, Bridget Nelson, et al.
Plos Pathogens|January 4, 2014
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsCelsa A Spina, Jenny Anderson, Nancie M Archin, et al.
The Journal of Infectious Diseases|February 13, 2024
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral TherapyCynthia L Gay, Patrick J Hanley, Shane D Falcinelli, et al.
Msphere|August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent IndividualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Msphere|September 8, 2021
Erratum for Markmann et al., "Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals"Alena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individualsAlena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Pageof 50